DRIO Logo

DarioHealth Corp. (DRIO) 

NASDAQ
Market Cap
$31.03M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
255 of 775
Rank in Industry
14 of 42

Largest Insider Buys in Sector

DRIO Stock Price History Chart

DRIO Stock Performance

About DarioHealth Corp.

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and …

Insider Activity of DarioHealth Corp.

Over the last 12 months, insiders at DarioHealth Corp. have bought $71,291 and sold $0 worth of DarioHealth Corp. stock.

On average, over the past 5 years, insiders at DarioHealth Corp. have bought $47,193 and sold $2.03M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Nelson Steven Charles (Chief Commercial Officer) — $48,511. Raphael Erez (Chief Executive Officer) — $22,780.

The last purchase of 5,000 shares for transaction amount of $4,546 was made by Nelson Steven Charles (Chief Commercial Officer) on 2024‑11‑12.

List of Insider Buy and Sell Transactions, DarioHealth Corp.

2024-11-12PurchaseChief Commercial Officer
5,000
0.0149%
$0.91$4,546-6.94%
2024-09-11PurchaseChief Commercial Officer
5,000
0.017%
$0.80$4,023+3.14%
2024-09-10PurchaseChief Commercial Officer
5,000
0.0179%
$0.84$4,221+23.23%
2024-09-09PurchaseChief Commercial Officer
5,000
0.0163%
$0.80$4,000+18.75%
2024-09-06PurchaseChief Commercial Officer
5,000
0.0168%
$0.84$4,201+15.91%
2024-09-05PurchaseChief Commercial Officer
5,000
0.017%
$0.82$4,091+20.81%
2024-08-27PurchaseChief Executive Officer
5,000
0.0172%
$0.88$4,400+11.65%
2024-08-23PurchaseChief Commercial Officer
5,000
0.017%
$0.95$4,750+1.96%
2024-08-22PurchaseChief Commercial Officer
5,000
0.0173%
$0.94$4,725+4.08%
2024-08-21PurchaseChief Executive Officer
5,000
0.017%
$0.95$4,750+1.05%
2024-08-21PurchaseChief Commercial Officer
5,000
0.0167%
$0.93$4,673+1.05%
2024-08-20PurchaseChief Executive Officer
5,000
0.0168%
$0.93$4,650+1.09%
2024-08-20PurchaseChief Commercial Officer
5,000
0.017%
$0.94$4,685+1.09%
2024-08-19PurchaseChief Executive Officer
5,000
0.0157%
$0.90$4,500-2.52%
2024-08-19PurchaseChief Commercial Officer
5,000
0.0161%
$0.92$4,599-2.52%
2024-08-16PurchaseChief Executive Officer
5,000
0.0157%
$0.90$4,480-0.01%
2023-05-04Purchasedirector
50
$3.37$169-39.59%
2023-05-04Purchasedirector
40
$3.37$135-39.59%
2023-05-04PurchaseChief Executive Officer
30
$3.37$101-39.59%
2023-05-04Purchasedirector
30
$3.37$101-39.59%

Insider Historical Profitability

181.45%
Raphael ErezChief Executive Officer
1937059
5.6811%
$0.91238+359.67%
Nelson Steven CharlesChief Commercial Officer
55000
0.1613%
$0.91110
Farhi Shmuel10 percent owner
329742
0.9671%
$0.9110
STERN ADAM Kdirector
69341
0.2034%
$0.91170+113.81%
Karah Hiladirector
49143
0.1441%
$0.91110<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Nantahala Capital Management Llc$4.03M8.82.63M+12.66%+$452,583.260.19
Appian Way Asset Management LP$2.04M4.461.33M+0.89%+$17,897.940.67
Y D More Investments Ltd$1.84M4.021.2M-6.66%-$131,254.080.25
Phoenix Holdings Ltd$1.81M3.951.18M0%+$00.03
Clal Insurance Enterprises Holdings Ltd$1.07M2.33698,362-20.27%-$271,605.470.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.